Your browser doesn't support javascript.
loading
Clinical pharmacokinetics after repeated intrapleural bupivacaine administration.
Debruyne, D; Moulin, M A; Tartiere, J; Bigot, M C; Gerard, J L; Bricard, H.
Afiliação
  • Debruyne D; Laboratory of Pharmacology, University Hospital Centre, Caen, France.
Clin Pharmacokinet ; 18(3): 240-4, 1990 Mar.
Article em En | MEDLINE | ID: mdl-2323154
ABSTRACT
Patients (n = 14) who underwent thoracotomy during surgery of the oesophagus for cancer received an initial intrapleural dose of 10 ml bupivacaine hydrochloride 2.5 mg/ml followed by repeated administration every 8 hours from the first to the fourth postoperative day. The mean (+/- SD) peak plasma drug concentration (Cmax) [352 +/- 120 micrograms/L], time to peak (tmax) [0.83 +/- 0.51 h], and first-order absorption rate constant (ka) [5.46 +/- 4.95 h-1] after the twelfth dose were significantly different from the Cmax (206 +/- 81 micrograms/L), tmax (1.8 +/- 1.2h), and ka (1.8 +/- 1.47 h-1) determined after the first dose. Half-life (3.5 +/- 2.2h) and mean concentration (204 +/- 105 micrograms/L) were not significantly different on the fourth day from those on the first (4.1 +/- 2.6h and 142 +/- 71 micrograms/L, respectively). No sharp peak corresponding to systemic toxicity and no accumulation could be expected with these low doses, administered at short intervals and providing good pain relief in this surgical series.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dor Pós-Operatória / Bupivacaína Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Pharmacokinet Ano de publicação: 1990 Tipo de documento: Article País de afiliação: França
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dor Pós-Operatória / Bupivacaína Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Pharmacokinet Ano de publicação: 1990 Tipo de documento: Article País de afiliação: França